Kazmirczak, F., Chen, K.-H., Adabag, S., Von Wald, L., Roukoz, H., Okasha, O., … Shenoy, C. (2019). VALIDATION AND REFINEMENT OF THE 2017 AHA/ACC/HRS GUIDELINE RECOMMENDATIONS FOR USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN CARDIAC SARCOIDOSIS. In JOURNAL OF INVESTIGATIVE MEDICINE (Vol. 67, pp. 869–869). Chicago, IL: BMJ PUBLISHING GROUP. https://doi.org/10.1136/jim-2019-midwestern2019.15

Kazmirczak, Felipe, Ko-Hsuan Chen, Selcuk Adabag, Lisa Von Wald, Henri Roukoz, Osama Okasha, Afshin Farzaneh-Far, Prabhjot S. Nijjar, Mehmet Akcakaya, and Chetan Shenoy. “VALIDATION AND REFINEMENT OF THE 2017 AHA/ACC/HRS GUIDELINE RECOMMENDATIONS FOR USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN CARDIAC SARCOIDOSIS.” In JOURNAL OF INVESTIGATIVE MEDICINE, 67:869–869. BMJ PUBLISHING GROUP, 2019. https://doi.org/10.1136/jim-2019-midwestern2019.15.

Kazmirczak F, Chen K-H, Adabag S, Von Wald L, Roukoz H, Okasha O, et al. VALIDATION AND REFINEMENT OF THE 2017 AHA/ACC/HRS GUIDELINE RECOMMENDATIONS FOR USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN CARDIAC SARCOIDOSIS. In: JOURNAL OF INVESTIGATIVE MEDICINE. BMJ PUBLISHING GROUP; 2019. p. 869–869.

Kazmirczak, Felipe, et al. “VALIDATION AND REFINEMENT OF THE 2017 AHA/ACC/HRS GUIDELINE RECOMMENDATIONS FOR USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN CARDIAC SARCOIDOSIS.” JOURNAL OF INVESTIGATIVE MEDICINE, vol. 67, no. 5, BMJ PUBLISHING GROUP, 2019, pp. 869–869. Wos, doi:10.1136/jim-2019-midwestern2019.15.

Kazmirczak F, Chen K-H, Adabag S, Von Wald L, Roukoz H, Okasha O, Farzaneh-Far A, Nijjar PS, Akcakaya M, Shenoy C. VALIDATION AND REFINEMENT OF THE 2017 AHA/ACC/HRS GUIDELINE RECOMMENDATIONS FOR USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN CARDIAC SARCOIDOSIS. JOURNAL OF INVESTIGATIVE MEDICINE. BMJ PUBLISHING GROUP; 2019. p. 869–869.